Research ArticleHuman Studies
Decision Tree Sensitivity Analysis for Cost-Effectiveness of FDG-PET in the Staging and Management of Non-Small-Cell Lung Carcinoma
S.S. Gambhir, C.K. Hoh, M.E. Phelps, I. Madar and J. Maddahi
Journal of Nuclear Medicine September 1996, 37 (9) 1428-1436;
S.S. Gambhir
C.K. Hoh
M.E. Phelps
I. Madar
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 37, Issue 9
September 1, 1996
Decision Tree Sensitivity Analysis for Cost-Effectiveness of FDG-PET in the Staging and Management of Non-Small-Cell Lung Carcinoma
S.S. Gambhir, C.K. Hoh, M.E. Phelps, I. Madar, J. Maddahi
Journal of Nuclear Medicine Sep 1996, 37 (9) 1428-1436;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Humana and 18F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others
- Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities--Phase III Studies
- Contribution of Imaging to Cancer Care Costs
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- Economic Evaluation of PET and PET/CT in Oncology: Evidence and Methodologic Approaches
- Cost-Effectiveness Analysis
- PET Evaluation of Lung Cancer
- Functional Imaging in Lung Cancer
- {gamma}-Camera 18F-FDG PET in Diagnosis and Staging of Patients Presenting with Suspected Lung Cancer and Comparison with Dedicated PET
- American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
- F-18 Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of Distant Metastases From Renal Cell Carcinoma
- PET in the follow-up of differentiated thyroid cancer
- Mediastinal Lymph Node Involvement in Non-Small Cell Lung Cancer: Evaluation with 99mTc-Tetrofosmin SPECT and Comparison with CT
- 18F-FDG PET for the Diagnosis and Grading of Soft-Tissue Sarcoma: A Meta-Analysis
- Clinical Impact of 18F-FDG PET in Thyroid Carcinoma Patients with Elevated Thyroglobulin Levels and Negative 131I Scanning Results After Therapy
- The Impact of PET on the Management of Lung Cancer: The Referring Physician's Perspective
- 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
- Whole body applications of positron emission tomography in oncology
- Impact of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography on Patient Management: First Year's Experience in a Clinical Center
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- Impact of 18F-FDG PET on Managing Patients with Colorectal Cancer: The Referring Physician's Perspective